Cargando…

Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases

In neurodegenerative diseases, cerebrospinal fluid analysis (CSF) is predominantly performed to exclude inflammatory diseases and to perform a risk assessment in dementive disorders by measurement of tau proteins and amyloid beta peptides. However, large scale data on basic findings of CSF routine p...

Descripción completa

Detalles Bibliográficos
Autores principales: Jesse, Sarah, Brettschneider, Johannes, Süssmuth, Sigurd D., Landwehrmeyer, Bernhard G., von Arnim, Christine A. F., Ludolph, Albert C., Tumani, Hayrettin, Otto, Markus
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101362/
https://www.ncbi.nlm.nih.gov/pubmed/21188408
http://dx.doi.org/10.1007/s00415-010-5876-x
_version_ 1782204278244376576
author Jesse, Sarah
Brettschneider, Johannes
Süssmuth, Sigurd D.
Landwehrmeyer, Bernhard G.
von Arnim, Christine A. F.
Ludolph, Albert C.
Tumani, Hayrettin
Otto, Markus
author_facet Jesse, Sarah
Brettschneider, Johannes
Süssmuth, Sigurd D.
Landwehrmeyer, Bernhard G.
von Arnim, Christine A. F.
Ludolph, Albert C.
Tumani, Hayrettin
Otto, Markus
author_sort Jesse, Sarah
collection PubMed
description In neurodegenerative diseases, cerebrospinal fluid analysis (CSF) is predominantly performed to exclude inflammatory diseases and to perform a risk assessment in dementive disorders by measurement of tau proteins and amyloid beta peptides. However, large scale data on basic findings of CSF routine parameters are generally lacking. The objective of the study was to define a normal reference spectrum of routine CSF parameters in neurodegenerative diseases. Routine CSF parameters (white cell count, lactate and albumin concentrations, CSF/serum quotients of albumin (Q (alb)), IgG, IgA, IgM, and oligoclonal IgG bands (OCB)) were retrospectively analyzed in an academic research setting. A total of 765 patients (Alzheimer’s disease (AD), Parkinson’s disease (PD), Parkinson’s disease dementia (PDD), vascular dementia (VD), frontotemporal lobar degeneration (FTLD), progressive supranuclear palsy (PSP), multisystem atrophy (MSA), motor neuron diseases (MND), spinocerebellar ataxia (SCA), Huntington’s disease (HD)) and non-demented control groups including a group of patients with muscular disorders (MD). The main outcome measures included statistical analyses of routine CSF parameters. Mildly elevated Q (alb) were found in a small percentage of nearly all subgroups and in a higher proportion of patients with PSP, MSA, VD, PDD, and MND. With the exception of 1 MND patient, no intrathecal Ig synthesis was observed. Isolated OCBs in CSF were sometimes found in patients with neurodegenerative diseases without elevated cell counts; lactate levels were always normal. A slightly elevated Q (alb) was observed in a subgroup of patients with neurodegenerative diseases and does not exclude the diagnosis. Extensive elevation of routine parameters is not characteristic and should encourage a re-evaluation of the clinical diagnosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00415-010-5876-x) contains supplementary material, which is available to authorized users.
format Text
id pubmed-3101362
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-31013622011-07-14 Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases Jesse, Sarah Brettschneider, Johannes Süssmuth, Sigurd D. Landwehrmeyer, Bernhard G. von Arnim, Christine A. F. Ludolph, Albert C. Tumani, Hayrettin Otto, Markus J Neurol Original Communication In neurodegenerative diseases, cerebrospinal fluid analysis (CSF) is predominantly performed to exclude inflammatory diseases and to perform a risk assessment in dementive disorders by measurement of tau proteins and amyloid beta peptides. However, large scale data on basic findings of CSF routine parameters are generally lacking. The objective of the study was to define a normal reference spectrum of routine CSF parameters in neurodegenerative diseases. Routine CSF parameters (white cell count, lactate and albumin concentrations, CSF/serum quotients of albumin (Q (alb)), IgG, IgA, IgM, and oligoclonal IgG bands (OCB)) were retrospectively analyzed in an academic research setting. A total of 765 patients (Alzheimer’s disease (AD), Parkinson’s disease (PD), Parkinson’s disease dementia (PDD), vascular dementia (VD), frontotemporal lobar degeneration (FTLD), progressive supranuclear palsy (PSP), multisystem atrophy (MSA), motor neuron diseases (MND), spinocerebellar ataxia (SCA), Huntington’s disease (HD)) and non-demented control groups including a group of patients with muscular disorders (MD). The main outcome measures included statistical analyses of routine CSF parameters. Mildly elevated Q (alb) were found in a small percentage of nearly all subgroups and in a higher proportion of patients with PSP, MSA, VD, PDD, and MND. With the exception of 1 MND patient, no intrathecal Ig synthesis was observed. Isolated OCBs in CSF were sometimes found in patients with neurodegenerative diseases without elevated cell counts; lactate levels were always normal. A slightly elevated Q (alb) was observed in a subgroup of patients with neurodegenerative diseases and does not exclude the diagnosis. Extensive elevation of routine parameters is not characteristic and should encourage a re-evaluation of the clinical diagnosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00415-010-5876-x) contains supplementary material, which is available to authorized users. Springer-Verlag 2010-12-25 2011 /pmc/articles/PMC3101362/ /pubmed/21188408 http://dx.doi.org/10.1007/s00415-010-5876-x Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Communication
Jesse, Sarah
Brettschneider, Johannes
Süssmuth, Sigurd D.
Landwehrmeyer, Bernhard G.
von Arnim, Christine A. F.
Ludolph, Albert C.
Tumani, Hayrettin
Otto, Markus
Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
title Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
title_full Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
title_fullStr Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
title_full_unstemmed Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
title_short Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
title_sort summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
topic Original Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101362/
https://www.ncbi.nlm.nih.gov/pubmed/21188408
http://dx.doi.org/10.1007/s00415-010-5876-x
work_keys_str_mv AT jessesarah summaryofcerebrospinalfluidroutineparametersinneurodegenerativediseases
AT brettschneiderjohannes summaryofcerebrospinalfluidroutineparametersinneurodegenerativediseases
AT sussmuthsigurdd summaryofcerebrospinalfluidroutineparametersinneurodegenerativediseases
AT landwehrmeyerbernhardg summaryofcerebrospinalfluidroutineparametersinneurodegenerativediseases
AT vonarnimchristineaf summaryofcerebrospinalfluidroutineparametersinneurodegenerativediseases
AT ludolphalbertc summaryofcerebrospinalfluidroutineparametersinneurodegenerativediseases
AT tumanihayrettin summaryofcerebrospinalfluidroutineparametersinneurodegenerativediseases
AT ottomarkus summaryofcerebrospinalfluidroutineparametersinneurodegenerativediseases